CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
41.40
-1.59 (-3.70%)
Mar 5, 2026, 4:00 PM EST - Market closed

CONMED Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,3751,3071,2451,0451,011
Revenue Growth (YoY)
5.18%5.00%19.06%3.45%17.18%
Cost of Revenue
624.25573.98568.5474.23442.6
Gross Profit
750.48733.03676.25571.25568.04
Selling, General & Admin
591.97478.28503.04454.04414.75
Research & Development
55.8854.4352.647.1543.57
Other Operating Expenses
0.42--112.011.13
Total Operating Expenses
648.27532.71555.64613.2459.45
Operating Income
102.2200.33120.6-41.96108.59
Interest Expense
-31.09-37.3-39.78-28.91-35.49
Total Non-Operating Income (Expense)
-31.09-37.3-39.78-28.91-35.49
Pretax Income
71.12163.0380.83-70.8673.11
Provision for Income Taxes
24.0630.6116.379.7210.56
Net Income
47.06132.4264.46-80.5862.54
Net Income to Common
47.06132.4264.46-80.5862.54
Net Income Growth
-64.47%105.44%--557.16%
Shares Outstanding (Basic)
3131313029
Shares Outstanding (Diluted)
3131323032
Shares Change (YoY)
-0.00%-1.26%5.02%-6.75%9.34%
EPS (Basic)
1.524.292.10-2.682.14
EPS (Diluted)
1.514.252.04-2.681.94
EPS Growth
-64.47%108.33%--506.25%
Free Cash Flow
150.88153.88106.3211.5896.9
Free Cash Flow Growth
-1.95%44.74%818.10%-88.05%88.10%
Free Cash Flow Per Share
4.844.943.370.393.01
Dividends Per Share
0.6000.8000.8000.8000.800
Dividend Growth
-25.00%----
Gross Margin
54.59%56.08%54.33%54.64%56.21%
Operating Margin
7.43%15.33%9.69%-4.01%10.74%
Profit Margin
3.42%10.13%5.18%-7.71%6.19%
FCF Margin
10.98%11.77%8.54%1.11%9.59%
EBITDA
176.49272.18192.4827.56179.33
EBITDA Margin
12.84%20.82%15.46%2.64%17.74%
EBIT
102.2200.33120.6-41.96108.59
EBIT Margin
7.43%15.33%9.69%-4.01%10.74%
Effective Tax Rate
33.83%18.77%20.25%-13.72%14.45%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q